October, 2011Bird Brain Recalls Pourable Gel Fuel Due to Burn and Flash Fire Hazards

The pourable gel fuel can ignite unexpectedly and splatter onto people and objects nearby when it is poured into a firepot that is still burning. This hazard can occur if the consumer does not see the flame or is not aware that the firepot is still ign…

LexisNexis® Legal News Podcast for Oct 5, 2011

A California state jury awards more than $48.1 million in a Motrin injury case, and, the U.S. Supreme Court will not review a dispute over royalties for online play and downloads of music. Hear these and other stories from LexisNexis® Mealey’s™ Pub…

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Ballard Designs Recalls Step Stools Due to Fall Hazard

Plastic tabs on the feet of the step stools can cause the stools to be unstable, posing a fall hazard to consumers.

LexisNexis® Legal News Podcast for Oct 4, 2011

Virginia petitions the U.S. Supreme Court over dismissal of a challenge to the Patient Protection and Affordable Care Act, and, a Fosamax MDL jury finds the drug was not defectively designed and did not cause a jaw injury. Hear these and other stories…

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Avastin Could Harm Fertility

Roche’s cancer drug Avastin could affect fertility in some women, the Food and Drug Administration is reporting. A new warning about “ovarian failure” has been added to Avastin’s label, and doctors are being advised to educate women of child-bearing age that Avastin may stop ovaries from releasing eggs regularly. Other updated information in the drug label includes a warning about the risk of blood clots and bleeding risk. The label also warns about possible side effects that include stroke, fatal …

LexisNexis® Legal News Podcast for Oct 3, 2011

The Illinois Supreme Court will not block the reopening of a $10 billion light cigarette action, and, a New Jersey appeals court affirms that hormone replacement therapy plaintiffs did not rebut label adequacy. Hear these and other stories from LexisNe…

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

FDA Concerned About Yaz

The FDA is remaining concerned about a type of birth control pill that could raise the risk of blood clots more than other pills on the market. The pills known as Yaz or Yasmin, marketed by Bayer AG, contain drospirenone. Drospirenone is a type of female sex hormone called a progestin. Although all birth control pills raise the risk of blood clots, some studies have reported that the risk of blood clots for women who use birth-control pills containing drospirenone …